TD Cowen Cuts Molina Healthcare (NYSE:MOH) Price Target to $412.00

Molina Healthcare (NYSE:MOH) had its target price cut by TD Cowen from $453.00 to $412.00 in a research report released on Tuesday, Benzinga reports. They currently have a buy rating on the stock.

MOH has been the topic of a number of other reports. Barclays reduced their price target on shares of Molina Healthcare from $437.00 to $430.00 and set an equal weight rating on the stock in a research report on Thursday, April 25th. Truist Financial boosted their price target on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a buy rating in a report on Tuesday, February 20th. Stephens reaffirmed an equal weight rating and issued a $390.00 price objective on shares of Molina Healthcare in a report on Thursday, April 25th. Cantor Fitzgerald reissued an overweight rating and set a $406.00 target price on shares of Molina Healthcare in a research note on Thursday, April 4th. Finally, StockNews.com cut Molina Healthcare from a strong-buy rating to a buy rating in a research report on Thursday, February 8th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of Hold and a consensus target price of $398.55.

Molina Healthcare Stock Up 0.0 %

MOH traded up $0.13 on Tuesday, reaching $339.68. The company’s stock had a trading volume of 373,104 shares, compared to its average volume of 402,516. The stock has a market cap of $19.91 billion, a price-to-earnings ratio of 18.43, a price-to-earnings-growth ratio of 1.04 and a beta of 0.54. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.49 and a quick ratio of 1.49. The business’s 50 day moving average is $384.15 and its 200 day moving average is $371.76. Molina Healthcare has a 1 year low of $266.35 and a 1 year high of $423.92.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, topping the consensus estimate of $5.46 by $0.27. The business had revenue of $9.93 billion for the quarter, compared to analysts’ expectations of $9.45 billion. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The company’s quarterly revenue was up 21.9% compared to the same quarter last year. During the same quarter last year, the company posted $5.81 earnings per share. As a group, research analysts forecast that Molina Healthcare will post 23.59 EPS for the current fiscal year.

Insider Activity at Molina Healthcare

In other Molina Healthcare news, Director Richard M. Schapiro sold 1,000 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total transaction of $401,050.00. Following the sale, the director now directly owns 11,207 shares of the company’s stock, valued at approximately $4,494,567.35. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In related news, Director Richard M. Schapiro sold 1,000 shares of the company’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $401.05, for a total transaction of $401,050.00. Following the transaction, the director now directly owns 11,207 shares of the company’s stock, valued at $4,494,567.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the sale, the chief financial officer now owns 36,531 shares of the company’s stock, valued at $14,121,423.36. The disclosure for this sale can be found here. Insiders sold 16,711 shares of company stock worth $6,472,517 in the last quarter. 1.10% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in MOH. Quent Capital LLC grew its holdings in shares of Molina Healthcare by 6.8% during the 1st quarter. Quent Capital LLC now owns 489 shares of the company’s stock valued at $201,000 after acquiring an additional 31 shares in the last quarter. Desjardins Global Asset Management Inc. raised its holdings in shares of Molina Healthcare by 4.4% during the 4th quarter. Desjardins Global Asset Management Inc. now owns 763 shares of the company’s stock valued at $276,000 after purchasing an additional 32 shares in the last quarter. Clear Creek Financial Management LLC lifted its stake in shares of Molina Healthcare by 2.2% in the 1st quarter. Clear Creek Financial Management LLC now owns 1,462 shares of the company’s stock valued at $601,000 after purchasing an additional 32 shares during the last quarter. Ritholtz Wealth Management boosted its holdings in Molina Healthcare by 2.1% in the fourth quarter. Ritholtz Wealth Management now owns 1,620 shares of the company’s stock worth $585,000 after purchasing an additional 33 shares in the last quarter. Finally, GAMMA Investing LLC lifted its position in shares of Molina Healthcare by 11.5% in the first quarter. GAMMA Investing LLC now owns 330 shares of the company’s stock worth $136,000 after buying an additional 34 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.